Companies: 10,795·Total market cap: $144.5T
Bionik Laboratories Corp.

Bionik Laboratories Corp.

BNKLOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$1248
P/E Ratio
52W High$0.0001
52W Low$0.0001
Overview

Bionik Laboratories Corp. (BNKL) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · BNKL · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.73bnkl eps ttm · bnkl earnings per shareEarnings history
PE Ratio (TTM)bnkl pe ratio ttm · bnkl price to earningsPE Ratio deep dive
Revenue (TTM)$1.8Mbnkl revenue ttm · bnkl annual revenueFull revenue history
Dividend YieldNo Dividenddoes bnkl pay dividends · bnkl dividend yieldDividend history
Shares Outstanding6.9Mbnkl shares outstanding · bnkl floatShares outstanding history
Next EarningsTBAbnkl earnings date · bnkl next earningsEarnings history

Financial Snapshot

Full Financials
FY 2023Revenue$1.8M▲ +41.73% YoY
202120222023
bionik laboratories corp. revenue · bnkl revenue 2023
FY 2023Net Income-$4.9M▲ +52.48% YoY
202120222023
bionik laboratories corp. net income · bnkl profit 2023
FY 2023EPS$-0.72▲ +59.55% YoY
202120222023
bnkl eps · bionik laboratories corp. earnings per share 2023
TTM:Revenue: $1.8MNet Income: -$5.1MEPS: $-0.73View income statement →

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+0.00%
1Y+0.00%
5Y-99.99%

About Bionik Laboratories Corp.

CEORichard Paul Russo Jr.
IPO DateMar 5, 2015
Employees12
CountryUS

Bionik Laboratories Corp. a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotio…

what is bionik laboratories corp. · bnkl stock overview · bionik laboratories corp. company profile · who is bionik laboratories corp. ceo · bnkl OTC · bionik laboratories corp. headquarters · bionik laboratories corp. business segments

About Stock Overview & Key Data

Bionik Laboratories Corp. (BNKL) is a Healthcare company in the Medical - Care Facilities industry, listed on OTC since Mar 5, 2015. As of the latest trading session, BNKL stock price is $0.00, with a market capitalization of $1,248. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.

In fiscal year 2023, Bionik Laboratories Corp. reported revenue of $1.8M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Bionik Laboratories Corp. (BNKL) stock price is $0.00. The stock is traded on OTC under the ticker symbol BNKL. The 52-week range is $0.00 – $0.00.

BNKL stock priceBNKL quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice